Charles Theuer - 21 Apr 2022 Form 4 Insider Report for Tracon Pharmaceuticals, Inc.

Role
President and CEO, Director
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
21 Apr 2022
Net transactions value
+$10,350
Form type
4
Filing time
25 Apr 2022, 06:00:10 UTC
Previous filing
12 Apr 2022
Next filing
03 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock Purchase $10,350 +4,500 +2% $2.30* 234,518 21 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2022.